|
HY-101257-25mg
|
MedChemexpress LLC
|
YKL-5-124 [CAS 1957203-01-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101257-5mg
|
MedChemexpress LLC
|
YKL-5-124 [CAS 1957203-01-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101257B-10mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
|
HY-101257B-100mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
|
HY-101257B-25mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
|
HY-101257B-5mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
|
HY-101257B-50mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
|
HY-101454-10mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-100mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-25mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-5mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-50mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101459-10mg
|
MedChemexpress LLC
|
RTC13 [CAS 1359825-94-7]
|
|
|
|
|
HY-101459-25mg
|
MedChemexpress LLC
|
RTC13 [CAS 1359825-94-7]
|
|
|
|
|
HY-101459-5mg
|
MedChemexpress LLC
|
RTC13 [CAS 1359825-94-7]
|
|
|
|
|
HY-101491-10mg
|
MedChemexpress LLC
|
SR-18292 [CAS 2095432-55-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101491-100mg
|
MedChemexpress LLC
|
SR-18292 [CAS 2095432-55-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101491-25mg
|
MedChemexpress LLC
|
SR-18292 [CAS 2095432-55-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101491-5mg
|
MedChemexpress LLC
|
SR-18292 [CAS 2095432-55-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101491-50mg
|
MedChemexpress LLC
|
SR-18292 [CAS 2095432-55-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101872A-10mg
|
MedChemexpress LLC
|
GSK-872 (hydrochloride) [CAS 2703752-81-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-101872A-100mg
|
MedChemexpress LLC
|
GSK-872 (hydrochloride) [CAS 2703752-81-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-101872A-25mg
|
MedChemexpress LLC
|
GSK-872 (hydrochloride) [CAS 2703752-81-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-101872A-5mg
|
MedChemexpress LLC
|
GSK-872 (hydrochloride) [CAS 2703752-81-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-101872A-50mg
|
MedChemexpress LLC
|
GSK-872 (hydrochloride) [CAS 2703752-81-0]
|
|
COVID-19-immunoregulation
|
|
